What is the recommended dose and frequency of metoclopramide (Intravenous (IV) or Intramuscular (IM)) for a 12-year-old patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metoclopramide IV/IM Dosing for a 12-Year-Old

For a 12-year-old child, administer metoclopramide 10 mg IV slowly over 1-2 minutes or IM, which can be repeated every 6-8 hours as needed, with a maximum daily dose not exceeding 30-40 mg. 1

Dose Calculation and Administration

Standard Dosing

  • Weight-based dosing: 0.1 mg/kg per dose is the recommended pediatric calculation 1
  • Fixed dose for age 12: Since children ≥14 years receive the adult dose of 10 mg, and children 6-14 years receive 2.5-5 mg for certain indications, a 12-year-old typically receives 10 mg per dose for most therapeutic uses 1
  • Route: Can be given either IV (slowly over 1-2 minutes) or IM 1

Frequency and Maximum Dosing

  • Frequency: Every 6-8 hours as needed 2
  • Maximum: Do not exceed 3-4 doses per day (30-40 mg total daily dose) to minimize risk of extrapyramidal reactions 3
  • Duration: Parenteral metoclopramide should be limited to 1-2 days of use 1

Critical Safety Considerations

Extrapyramidal Reaction Risk

  • Children and adolescents are at significantly higher risk for acute extrapyramidal reactions (EPRs) compared to older adults, with rates of 15-33% reported at higher doses 3
  • Prophylactic diphenhydramine (25-50 mg IV or IM) should be strongly considered when administering metoclopramide to reduce EPR risk 3
  • If acute dystonic reactions occur, immediately inject 50 mg diphenhydramine IM, and symptoms usually subside 1

Administration Technique

  • IV route: Must be given slowly over 1-2 minutes to reduce side effects 1
  • Never give as rapid IV push, as this increases risk of adverse reactions 1
  • For doses requiring dilution (>10 mg), use 50 mL of normal saline and infuse over at least 15 minutes 1

Common Pitfalls to Avoid

Duration of Use

  • Do not use for more than 1-2 days parenterally 1
  • Prolonged use significantly increases risk of tardive dyskinesia and other movement disorders 4
  • Even short-term, low-dose use has been associated with long-lasting adverse effects in young patients 4

Consecutive Day Dosing

  • Children receiving metoclopramide on consecutive days have higher frequency of EPRs 3
  • If multi-day treatment is necessary, consider alternative antiemetics or transition to oral route after initial parenteral dose 1

Monitoring Requirements

  • Watch for restlessness, drowsiness, akathisia (motor restlessness), and involuntary movements 3, 5
  • Monitor for dystonic reactions (muscle spasms, particularly of neck and face) which require immediate treatment 1
  • Symptoms may include twitches, jerks, tremors of eyelids, tongue, neck, fingers, arms and legs 4

Indication-Specific Dosing

For Severe Nausea/Vomiting

  • 10 mg IV/IM as single dose, may repeat every 6-8 hours 1
  • Consider diphenhydramine prophylaxis 3

For Chemotherapy-Induced Emesis (if applicable)

  • Higher doses (1-2 mg/kg) have been studied but carry substantially higher risk of EPRs (15-33%) 3
  • Not recommended without specialist consultation and mandatory diphenhydramine co-administration 3

Renal Impairment Adjustment

  • If creatinine clearance <40 mL/min, reduce dose by 50% and increase dosing interval 1
  • Metoclopramide is primarily renally excreted 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985

Research

Metoclopramide: pharmacology and clinical application.

Annals of internal medicine, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.